The newly founded biotech start-up myotwin GmbH aims to transform drug development for cardiovascular diseases by creating a digital twin of the human heart.

Cardiovascular diseases remain the leading cause of death worldwide and generate healthcare costs in the hundreds of billions each year in Europe alone. Despite this burden, drug development has largely stagnated. One major challenge is the limited reliability of animal models, which differ significantly from the human heart and therefore provide only limited predictive value. […]

Contact

Would you like to work with us and kickstart your project?

We look forward to hearing from you!
Leave your contact details and a few keywords about your enquiry – our team will get back to you personally as soon as possible.